Trials Sponsors Conditions Drugs Pricing

Conditions

Eye Movement

Outcome Measures

Primary Outcomes (2)

Efficacy of data capture
Capturing \>50 different oculometric measures in \>95% of a cohort of up to 2000 subjects
36 months
Validation of data capture
Relative root mean square error (RMSE) of NeuraLight's extracted oculometric measures compared with retrieved measurements from a validated eye tracking system \<0.1
36 months

Secondary Outcomes (1)

Optimization of data capture
36 months

Study Arms (1)

Healthy Data Collection

As a part of the study, a group of up to 2000 healthy subjects will undergo a NeuraLight session including oculometric measurements and eye-tracking recordings using a novel software-based platform and an eye-tracking system (approx. 15 minutes). The oculometric evaluation will occur for every patient 1 time, and all subjects will be recruited over a period of 36 months. All assessments will be performed during a clinic visit unless authorized to be conducted remotely

Other: NeuraLight

Interventions

NeuraLightOther

NeuraLight is an investigational software-based platform used for measuring eye movements in response to visual stimuli and captured using a simple webcam

Healthy Data Collection

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 90 Years

Sexall

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

Healthy subjects

You may qualify if:

Men and women ages between 18 and 90 years old
Normal or corrected vision

Sponsors & Collaborators

NeuraLight
Industrylead

Study Sites (1)

NeuraLight

Wilmington, Delaware, 19801, United States

RECRUITING

Eitan Raveh, PhDCONTACT

Study Officials

Eitan Raveh, PhD
NeuraLight
PRINCIPAL INVESTIGATOR

Central Study Contacts

Eitan Raveh, PhD

CONTACT

+972-58-6277947 eitan@neuralight.ai

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: INDUSTRY
Responsible Party: SPONSOR

Study Record Dates

First Submitted

July 25, 2022

First Posted

July 27, 2022

Study Start

July 22, 2022

Actual (reported)

Primary Completion

December 31, 2026

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (1)

Study Arms (1)

Healthy Data Collection

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (1)

Study Arms (1)

Healthy Data Collection

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations